According to still unconfirmed reports from a well-known 'Phone Chip Expert' profile on the Weibo platform, Apple is developing its own AI server processor, possibly using TSMC's (TSM.US) 3nm technology. The company's stock managed to erase a weaker opening today on the wave of these reports, but overall shares of the company are little changed today. Investors are still trying to estimate how much AI will compensate the company for weaker iPhone sales, especially in China.
- The company's goal is to be in mass production by the second half of 2025. Β Taiwan supplies the company with all of its custom silicon chips. 3nm technology is one of the most advanced semiconductor processes available. It brings decisive improvements in performance and efficiency compared to 5 nm and 7 nm. Developing our own AI processors, means optimizing and working toward so-called vertical integration of the supply chain.
- By designing its own server chips, the company can tailor the hardware specifically to its needs, increasing performance, without the cost of additional intermediaries. AI processors could be used, among other things, to increase the performance of data centers and possibly cloud-based AI tools implemented in the future,
- The comments confirm that Apple is on the path of a real business transformation, oriented toward AI. The aforementioned Weibo platform user repeatedly hit back with predictions about iPhone models or A15/A16 processors. His comments were later confirmed by many credible sources and product launches.
Apple lost more than 19% of its smartphone market share, year-on-year, in China, mostly to Chinese smartphones producers. Source: Counterpoint Research
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appApple (AAPL.US) chart, D1 interval.
Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.